How many insider trades does FilingIQ track for NUVB?

FilingIQ tracks 137 Form 4 insider transactions for NUVB (Nuvation Bio Inc.), covering filings from Feb 10, 2020 onwards. 22 of those were filed in the last 90 days.

Are NUVB insiders net buyers or net sellers?

Across the full Form 4 history for NUVB, 39 transactions (28%) were open-market purchases and 25 (18%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NUVB insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NUVB in?

Nuvation Bio Inc. (NUVB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.49B.

NUVB insider trading

NYSE Healthcare

Nuvation Bio Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

137

Last 90 days

Buys / sells

28% / 18%

Market cap

$1.49B

About Nuvation Bio Inc.

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. The company is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 2 clinical trials; NUV-1511, a drug-drug conjugate for use in chemotherapy agent that suppresses the growth of various advanced solid tumors; and NUV-868, a binding domain 2 bromodomain and extra-terminal inhibitor that inhibits bromodomain-containing protein 4. The company was founded in 2018 and is headquartered in New York, New York.

Company website: www.nuvationbio.com

NUVB insider activity at a glance

FilingIQ has scored 137 insider transactions for NUVB since Feb 10, 2020. The most recent filing in our index is dated Apr 17, 2026.

Across the full history, 39 open-market purchases and 25 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NUVB insider trades is 58.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NUVB trades on FilingIQ Raw filings on SEC EDGAR

Latest NUVB Form 4 filings

Sauvage Philippe Chief Financial Officer

P Jun 17, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding NUVB

Laurion Capital Management LP

$70.36M · 2.6% of AUM

Frequently asked

How many insider trades does FilingIQ track for NUVB?: FilingIQ tracks 137 Form 4 insider transactions for NUVB (Nuvation Bio Inc.), covering filings from Feb 10, 2020 onwards. 22 of those were filed in the last 90 days.
Are NUVB insiders net buyers or net sellers?: Across the full Form 4 history for NUVB, 39 transactions (28%) were open-market purchases and 25 (18%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NUVB insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NUVB in?: Nuvation Bio Inc. (NUVB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.49B.

Methodology & sources

Every NUVB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.